University of Michigan to start clinical trial for cancer-related pain

As reported by The BioTech Web, the University of Michigan will begin a clinical trial. This Phase I trial will be for gene therapy for untraceable pain for cancer patients. They're testing a vector created from herpes simplex virus (that which creates cold sores) to deliver for the gene enkephalin, which is a pain releiver produced by the body. They are looking for the trial to have twelve patients.